Correction to: Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14/AKT pathway
Jiaxin Ge, Ji Dai, Haoqiang Ji, Jie Guo, Xiaoban Shen, Desen Sun, Qiang Chen, Pan Chen, Guoliang Ye, Junming Guo, Shuangshuang Zhang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Mechanisms and Therapy · Cancer-related molecular mechanisms research · RNA modifications and cancer
Correction to: Cell Death Discovery 10.1038/s41420-025-02514-9, published online 15 May 2025
In this article on page 4, lines 17 and 18 of Table 1: The correct number of “NO” situation in the high group is “18”; the correct number of “N1 &N2&N3” situation in the high group is “41”; the correct number of “NO” situation in the low group is “19”; the correct number of “N1&N2&N3” situation in the low group is “41”. The percentage and the total number (n) in the column 2 have been corrected accordingly.Table 1. The correlation between the amount of tRF-29-79MP9P9NH525 in tissues and clinicopathological features of advanced gastric cancer patients.Characteristicsn (%)High (%)Low (%)P-valueAll cases1195960Gender>0.9999 Male71 (59.66)35 (59.32)36 (60.00) Female48 (40.34)24 (40.68)24 (40.00)**Age (y)**0.1627 ≥6083 (69.75)45 (76.27)38 (63.33) <6036 (30.25)14 (23.73)22 (36.67)Differentiation0.0107 Well9 (7.56)5 (8.48)4 (6.67) Moderate68 (57.14)41 (69.49)27 (45.00) Poor42 (35.30)13 (22.03)29 (48.33)Lymphatic node metastasis>0.9999 N037 (31.09)18 (30.51)19 (31.67) N1 & N2 & N382 (68.91)41 (69.49)41 (68.33)Invasion0.1563 T239 (32.77)20 (33.90)19 (31.67) T37 (5.88)1 (1.69)6 (10.00) T473 (61.35)38 (64.41)35 (58.33)**Tumor size (cm)**0.0278 ≥563 (52.94)25 (42.37)38 (63.33) <556 (47.06)34 (57.63)22 (36.67)Distal metastasis0.3644 Yes4 (3.36)3 (5.08)1 (1.67) No115 (96.64)56 (94.92)59 (98.33)TNM stage0.6373 IB25 (21.00)13 (22.03)12 (20.00) IIA & IIB24 (20.17)10 (16.95)14 (23.33) IIIA & IIIB & IIIC66 (55.46)33 (55.93)33 (55.00) IV4 (3.36)3 (5.09)1 (1.67)Vessel invasion>0.9999 Yes85 (71.43)42 (71.19)43 (71.67) No34 (28.57)17 (28.81)17 (28.33)Lymphatic invasion0.6883 Yes84 (70.59)43 (72.88)41 (68.33) No35 (29.41)16 (27.12)19 (31.67)Nerve invasion0.0877 Yes76 (63.87)33 (55.93)43 (71.67) No43 (36.13)26 (44.07)17 (28.33)**Ki-67 (%)**0.3689 >3094 (78.99)49 (83.05)45 (75.00) ≤3025 (21.01)10 (16.95)15 (25.00)
Line 21 of Table 1: The correct percentage of low group is “10.00”.
Line 25 of Table 1: The correct percentage of low group is “36.67”.
Line 30 of Table 1: The correct percentage of low group is “20.00”.
Line 44 of Table 1: The correct content is “>30”.
The original article has been corrected.